<DOC>
	<DOCNO>NCT02783183</DOCNO>
	<brief_summary>The purpose trial compare pharmacokinetic characteristic YHD1119 ( Pregabalin 300mg ) Lyrica capsule ( Pregabalin 150mg ) . YHD1119 control release formulation make Yuhan Corporation . Primary endpoint Cmax , s AUCtau secondary endpoint AUClast , s , AUCinf , s , Tmax , s t1/2 .</brief_summary>
	<brief_title>A Open-label , Randomized , Crossover Study Assess PK Pregabalin</brief_title>
	<detailed_description />
	<mesh_term>Pregabalin</mesh_term>
	<criteria>19~50 year old , healthy male volunteer &gt; 55Kg ( Body weight ) 18.5 &lt; BMI &lt; 28 AST ALT &gt; 3 * Upper normal range ( Lab ) Total bilirubin &gt; 2.0 mg/dl Systolic BP &gt; 140 OR &lt; 90 , Diastolic BP &gt; 100 OR &lt; 60</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>